lovastatin has been researched along with Constriction, Pathological in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavero, PG; Hartzler, GO; Kacich, RL; Kahn, J; Ligon, R; Maddex, C; McCallister, BD; O'Keefe, JH; Stone, GW | 1 |
| Boccuzzi, SJ; Ghazzal, ZM; King, SB; Klein, L; Kosinski, AS; Waksman, R; Weintraub, WS | 1 |
1 trial(s) available for lovastatin and Constriction, Pathological
| Article | Year |
|---|---|
Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Constriction, Pathologic; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lipoproteins; Lovastatin; Male; Middle Aged; Probucol; Recurrence | 1996 |
1 other study(ies) available for lovastatin and Constriction, Pathological
| Article | Year |
|---|---|
Relation of lumen size to restenosis after percutaneous transluminal coronary balloon angioplasty. Lovastatin Restenosis Trial Group.
Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Constriction, Pathologic; Coronary Disease; Humans; Lovastatin; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 1996 |